Multiple myeloma (MM) is a hematologic malignancy characterized by high genomic instability. Here we provide evidence that hyper-activation of DNA ligase III (LIG3) is crucial for genomic instability and survival of MM cells. LIG3 mRNA expression in MM patients correlates with shorter survival and even increases with more advanced stage of disease. Knockdown of LIG3 impairs MM cells viability in vitro and in vivo, suggesting that neoplastic plasmacells are dependent on LIG3-driven repair. To investigate the mechanisms involved in LIG3 expression, we investigated the post-transcriptional regulation. We identified miR-22-3p as effective negative regulator of LIG3 in MM. Enforced expression of miR-22 in MM cells downregulated LIG3 protein, which in turn increased DNA damage inhibiting in vitro and in vivo cell growth. Taken together, our findings demonstrate that myeloma cells are addicted to LIG3, which can be effectively inhibited by miR-22, promoting a novel axis of genome stability regulation.

miR-22 suppresses DNA ligase III addiction in multiple myeloma / D. Caracciolo, M.T. Di Martino, N. Amodio, E. Morelli, M. Montesano, C. Botta, F. Scionti, D. Talarico, E. Altomare, M.E. Gallo Cantafio, V. Zuccalà, L. Maltese, K. Todoerti, M. Rossi, M. Arbitrio, A. Neri, P. Tagliaferri, P. Tassone. - In: LEUKEMIA. - ISSN 0887-6924. - (2018). [Epub ahead of print] [10.1038/s41375-018-0238-2]

miR-22 suppresses DNA ligase III addiction in multiple myeloma

K. Todoerti;A. Neri;
2018

Abstract

Multiple myeloma (MM) is a hematologic malignancy characterized by high genomic instability. Here we provide evidence that hyper-activation of DNA ligase III (LIG3) is crucial for genomic instability and survival of MM cells. LIG3 mRNA expression in MM patients correlates with shorter survival and even increases with more advanced stage of disease. Knockdown of LIG3 impairs MM cells viability in vitro and in vivo, suggesting that neoplastic plasmacells are dependent on LIG3-driven repair. To investigate the mechanisms involved in LIG3 expression, we investigated the post-transcriptional regulation. We identified miR-22-3p as effective negative regulator of LIG3 in MM. Enforced expression of miR-22 in MM cells downregulated LIG3 protein, which in turn increased DNA damage inhibiting in vitro and in vivo cell growth. Taken together, our findings demonstrate that myeloma cells are addicted to LIG3, which can be effectively inhibited by miR-22, promoting a novel axis of genome stability regulation.
Settore MED/15 - Malattie del Sangue
17-ago-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
Caracciolo_Leukemia_2018.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 2.77 MB
Formato Adobe PDF
2.77 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/586033
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 33
social impact